Back
37
4
Also listed as
PGENY
OTC
Day Range
$10.32
$12.42
52-Week Range
$10.32
$12.42
Volume
12,000
50D / 200D Avg
$11.92
/
$12.14
Prev Close
$10.32
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.1 | 10.4 |
| P/B | 0.0 | 1.2 |
| ROE % | 10.5 | 12.3 |
| Net Margin % | 7.9 | 5.2 |
| Rev Growth 5Y % | 4.1 | 5.5 |
| D/E | 0.0 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$95.90
$92.49 – $100.70
|
130 B | 1 |
| FY2029 |
$90.74
$87.51 – $95.27
|
120 B | 1 |
| FY2028 |
$94.07
$90.72 – $98.77
|
120 B | 1 |
Key Takeaways
Revenue grew 4.09% annually over 5 years — modest growth
ROE of 10.45% — decent returns on equity
Debt/Equity of 0.02 — conservative balance sheet
Generating 10.27B in free cash flow
P/E of 0.14 — trading at a low valuation
Cash machine — converts 119.72% of earnings into free cash flow
Growth
Revenue Growth (5Y)
4.09%
Revenue (1Y)4.89%
Earnings (1Y)2.48%
FCF Growth (3Y)7.58%
Quality
Return on Equity
10.45%
ROIC11.71%
Net Margin7.85%
Op. Margin12.05%
Safety
Debt / Equity
0.02
Current Ratio4.22
Interest Coverage153.01
Valuation
P/E Ratio
0.14
P/B Ratio0.01
EV/EBITDA-2.81
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.89% | Revenue Growth (3Y) | 7.55% |
| Earnings Growth (1Y) | 2.48% | Earnings Growth (3Y) | 7.50% |
| Revenue Growth (5Y) | 4.09% | Earnings Growth (5Y) | -0.59% |
| Profitability | |||
| Revenue (TTM) | 109.27B | Net Income (TTM) | 8.58B |
| ROE | 10.45% | ROA | 7.79% |
| Gross Margin | 50.23% | Operating Margin | 12.05% |
| Net Margin | 7.85% | Free Cash Flow (TTM) | 10.27B |
| ROIC | 11.71% | FCF Growth (3Y) | 7.58% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 4.22 |
| Interest Coverage | 153.01 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 0.14 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | 8.84 |
| EV/EBITDA | -2.81 | Dividend Yield | 0.04% |
| Market Cap | 1.23B | Enterprise Value | -37.05B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 109.27B | 104.17B | 94.46B | 94.92B | 93.08B |
| Net Income | 8.58B | 8.37B | 7.42B | 8.58B | 8.79B |
| EPS (Diluted) | 72.15 | 70.00 | 62.06 | 71.72 | 73.43 |
| Gross Profit | 54.89B | 51.37B | 45.45B | 44.83B | 44.07B |
| Operating Income | 13.17B | 12.14B | 10.73B | 12.20B | 13.34B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 110.18B | 108.31B | 100.44B | 101.73B | 98.04B |
| Total Liabilities | 24.22B | 23.70B | 19.35B | 21.78B | 21.23B |
| Shareholders' Equity | 82.99B | 81.14B | 77.58B | 76.70B | 73.88B |
| Total Debt | 1.36B | 1.77B | 1.90B | 2.06B | 1.94B |
| Cash & Equivalents | 39.64B | 39.20B | 34.36B | 34.28B | 35.22B |
| Current Assets | 76.63B | 73.46B | 64.80B | 67.14B | 66.25B |
| Current Liabilities | 18.14B | 17.38B | 13.53B | 15.56B | 15.07B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#493 of 820
#630 of 708
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026